These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 22732654

  • 1. Allosteric modulation of alpha4beta2 nicotinic acetylcholine receptors by HEPES.
    Weltzin MM, Huang Y, Schulte MK.
    Eur J Pharmacol; 2014 Jun 05; 732():159-68. PubMed ID: 22732654
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of the allosteric modulator desformylflustrabromine and its interaction with alpha4beta2 neuronal nicotinic acetylcholine receptor orthosteric ligands.
    Weltzin MM, Schulte MK.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):917-26. PubMed ID: 20516140
    [Abstract] [Full Text] [Related]

  • 3. Desformylflustrabromine Modulates α4β2 Neuronal Nicotinic Acetylcholine Receptor High- and Low-Sensitivity Isoforms at Allosteric Clefts Containing the β2 Subunit.
    Weltzin MM, Schulte MK.
    J Pharmacol Exp Ther; 2015 Aug 01; 354(2):184-94. PubMed ID: 26025967
    [Abstract] [Full Text] [Related]

  • 4. Deconstruction of the α4β2 nicotinic acetylcholine receptor positive allosteric modulator desformylflustrabromine.
    German N, Kim JS, Jain A, Dukat M, Pandya A, Ma Y, Weltzin M, Schulte MK, Glennon RA.
    J Med Chem; 2011 Oct 27; 54(20):7259-67. PubMed ID: 21905680
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Allosteric modulation of α4β2* nicotinic acetylcholine receptors: Desformylflustrabromine potentiates antiallodynic response of nicotine in a mouse model of neuropathic pain.
    Bagdas D, Ergun D, Jackson A, Toma W, Schulte MK, Damaj MI.
    Eur J Pain; 2018 Jan 27; 22(1):84-93. PubMed ID: 28809075
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
    Wang ZJ, Deba F, Mohamed TS, Chiara DC, Ramos K, Hamouda AK.
    J Biol Chem; 2017 Jun 16; 292(24):9988-10001. PubMed ID: 28446611
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis of desformylflustrabromine and its evaluation as an alpha4beta2 and alpha7 nACh receptor modulator.
    Kim JS, Padnya A, Weltzin M, Edmonds BW, Schulte MK, Glennon RA.
    Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4855-60. PubMed ID: 17604168
    [Abstract] [Full Text] [Related]

  • 12. 5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors.
    Zwart R, Broad LM, Xi Q, Lee M, Moroni M, Bermudez I, Sher E.
    Eur J Pharmacol; 2006 Jun 06; 539(1-2):10-7. PubMed ID: 16674940
    [Abstract] [Full Text] [Related]

  • 13. Diverse actions of neonicotinoids on chicken alpha7, alpha4beta2 and Drosophila-chicken SADbeta2 and ALSbeta2 hybrid nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes.
    Ihara M, Matsuda K, Otake M, Kuwamura M, Shimomura M, Komai K, Akamatsu M, Raymond V, Sattelle DB.
    Neuropharmacology; 2003 Jul 06; 45(1):133-44. PubMed ID: 12814666
    [Abstract] [Full Text] [Related]

  • 14. Desformylflustrabromine: A Novel Positive Allosteric Modulator for beta2 Subunit Containing Nicotinic Receptor Sub-Types.
    Pandya AA.
    Curr Pharm Des; 2016 Jul 06; 22(14):2057-63. PubMed ID: 26818864
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
    Hamouda AK, Bautista MR, Akinola LS, Alkhlaif Y, Jackson A, Carper M, Toma WB, Garai S, Chen YC, Thakur GA, Fowler CD, Damaj MI.
    Neuropharmacology; 2021 Jun 01; 190():108568. PubMed ID: 33878302
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
    Papke RL, Trocmé-Thibierge C, Guendisch D, Al Rubaiy SA, Bloom SA.
    J Pharmacol Exp Ther; 2011 May 01; 337(2):367-79. PubMed ID: 21285282
    [Abstract] [Full Text] [Related]

  • 20. Differential inhibition of nicotine- and acetylcholine-evoked currents through alpha4beta2 neuronal nicotinic receptors by tobacco cembranoids in Xenopus oocytes.
    Eaton MJ, Ospina CA, Rodríguez AD, Eterović VA.
    Neurosci Lett; 2004 Aug 05; 366(1):97-102. PubMed ID: 15265598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.